ESR1 Mutation Testing in Breast Cancer: Setting the Standard for Personalized Oncology?

Is your patient progressing on an aromatase inhibitor (AI)? Fine-tune ddPCR/NGS testing to detect resistance and optimize oral selective estrogen receptor degrader (SERD) success.

Credit available for this activity expires: 11/04/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/esr1-mutation-testing-breast-cancer-setting-standard-2025a1000u0f?ecd=bdc_podcast_libsyn_mscpedu